-
1
-
-
0032545355
-
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
-
Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T and Higashio K. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochemical and biophysical research communications. 1998; 253:395-400.
-
(1998)
Biochemical and biophysical research communications
, vol.253
, pp. 395-400
-
-
Nakagawa, N.1
Kinosaki, M.2
Yamaguchi, K.3
Shima, N.4
Yasuda, H.5
Yano, K.6
Morinaga, T.7
Higashio, K.8
-
2
-
-
0030714605
-
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
-
Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D and Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997; 390:175-179.
-
(1997)
Nature
, vol.390
, pp. 175-179
-
-
Anderson, D.M.1
Maraskovsky, E.2
Billingsley, W.L.3
Dougall, W.C.4
Tometsko, M.E.5
Roux, E.R.6
Teepe, M.C.7
DuBose, R.F.8
Cosman, D.9
Galibert, L.10
-
3
-
-
0033104614
-
TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cell
-
Josien R, Wong BR, Li HL, Steinman RM and Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. Journal of immunology (Baltimore, Md: 1950). 1999; 162:2562-2568.
-
(1999)
Journal of immunology (Baltimore, Md: 1950)
, vol.162
, pp. 2562-2568
-
-
Josien, R.1
Wong, B.R.2
Li, H.L.3
Steinman, R.M.4
Choi, Y.5
-
4
-
-
0034730327
-
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
-
Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, Boyle WJ, Khokha R and Penninger JM. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 2000; 103:41-50.
-
(2000)
Cell
, vol.103
, pp. 41-50
-
-
Fata, J.E.1
Kong, Y.Y.2
Li, J.3
Sasaki, T.4
Irie-Sasaki, J.5
Moorehead, R.A.6
Elliott, R.7
Scully, S.8
Voura, E.B.9
Lacey, D.L.10
Boyle, W.J.11
Khokha, R.12
Penninger, J.M.13
-
5
-
-
67650924224
-
Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
-
Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M and Okada Y. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. Journal of Pathology. 2009; 218:530-539.
-
(2009)
Journal of Pathology
, vol.218
, pp. 530-539
-
-
Mikami, S.1
Katsube, K.2
Oya, M.3
Ishida, M.4
Kosaka, T.5
Mizuno, R.6
Mochizuki, S.7
Ikeda, T.8
Mukai, M.9
Okada, Y.10
-
6
-
-
33645453481
-
Regulation of cancer cell migration and bone metastasis by RANKL
-
Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006; 440:692-696.
-
(2006)
Nature
, vol.440
, pp. 692-696
-
-
Jones, D.H.1
Nakashima, T.2
Sanchez, O.H.3
Kozieradzki, I.4
Komarova, S.V.5
Sarosi, I.6
Morony, S.7
Rubin, E.8
Sarao, R.9
Hojilla, C.V.10
Komnenovic, V.11
Kong, Y.Y.12
Schreiber, M.13
-
7
-
-
79951804629
-
RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation
-
Chen L-M, Kuo C-H, Lai T-Y, Lin Y-M, Su C-C, Hsu H-H, Tsai F-J, Tsai C-H, Huang C-Y and Tang C-H. RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. Journal of Cellular Biochemistry. 2011; 112:933-941.
-
(2011)
Journal of Cellular Biochemistry
, vol.112
, pp. 933-941
-
-
Chen, L.-M.1
Kuo, C.-H.2
Lai, T.-Y.3
Lin, Y.-M.4
Su, C.-C.5
Hsu, H.-H.6
Tsai, F.-J.7
Tsai, C.-H.8
Huang, C.-Y.9
Tang, C.-H.10
-
8
-
-
78650671134
-
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases
-
Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Fratto ME, Sabbatini R, Della Pepa C, Porta C, Del Conte A, et al. Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases. Journal of Cellular Physiology. 2011; 226:780-784.
-
(2011)
Journal of Cellular Physiology
, vol.226
, pp. 780-784
-
-
Santini, D.1
Perrone, G.2
Roato, I.3
Godio, L.4
Pantano, F.5
Grasso, D.6
Russo, A.7
Vincenzi, B.8
Fratto, M.E.9
Sabbatini, R.10
Della Pepa, C.11
Porta, C.12
Del Conte, A.13
-
9
-
-
84861854171
-
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis
-
Palafox M, Ferrer I, Pellegrini P, Vila S, Hernandez-Ortega S, Urruticoechea A, Climent F, Soler MT, Munoz P, Vinals F, Tometsko M, Branstetter D, Dougall WC, et al. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. Cancer research. 2012; 72:2879-2888.
-
(2012)
Cancer research
, vol.72
, pp. 2879-2888
-
-
Palafox, M.1
Ferrer, I.2
Pellegrini, P.3
Vila, S.4
Hernandez-Ortega, S.5
Urruticoechea, A.6
Climent, F.7
Soler, M.T.8
Munoz, P.9
Vinals, F.10
Tometsko, M.11
Branstetter, D.12
Dougall, W.C.13
-
10
-
-
79952193038
-
Tumour-infifiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
-
Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM and Karin M. Tumour-infifiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature. 2011; 470:548-553.
-
(2011)
Nature
, vol.470
, pp. 548-553
-
-
Tan, W.1
Zhang, W.2
Strasner, A.3
Grivennikov, S.4
Cheng, J.Q.5
Hoffman, R.M.6
Karin, M.7
-
11
-
-
79955772442
-
Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
-
Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, La Verde N, Caroti C, Treilleux I, et al. Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients. PLoS One. 2011; 6:e19234.
-
(2011)
PLoS One
, vol.6
-
-
Santini, D.1
Schiavon, G.2
Vincenzi, B.3
Gaeta, L.4
Pantano, F.5
Russo, A.6
Ortega, C.7
Porta, C.8
Galluzzo, S.9
Armento, G.10
La Verde, N.11
Caroti, C.12
Treilleux, I.13
-
12
-
-
84901694948
-
RANK expression as a prognostic and predictive marker in breast cancer
-
Pfifitzner BM, Branstetter D, Loibl S, Denkert C, Lederer B, Schmitt WD, Dombrowski F, Werner M, Rudiger T, Dougall WC and von Minckwitz G. RANK expression as a prognostic and predictive marker in breast cancer. Breast Cancer Research and Treatment. 2014;145:307-315.
-
(2014)
Breast Cancer Research and Treatment
, vol.145
, pp. 307-315
-
-
Pfifitzner, B.M.1
Branstetter, D.2
Loibl, S.3
Denkert, C.4
Lederer, B.5
Schmitt, W.D.6
Dombrowski, F.7
Werner, M.8
Rudiger, T.9
Dougall, W.C.10
von Minckwitz, G.11
-
13
-
-
84908548743
-
OPG and PgR show similar cohort specifific effects as prognostic factors in ER positive breast cancer
-
Sanger N, Ruckhaberle E, Bianchini G, Heinrich T, Milde-Langosch K, Muller V, Rody A, Solomayer EF, Fehm T, Holtrich U, Becker S and Karn T. OPG and PgR show similar cohort specifific effects as prognostic factors in ER positive breast cancer. Molecular Oncology. 2014;8:1196-1207.
-
(2014)
Molecular Oncology
, vol.8
, pp. 1196-1207
-
-
Sanger, N.1
Ruckhaberle, E.2
Bianchini, G.3
Heinrich, T.4
Milde-Langosch, K.5
Muller, V.6
Rody, A.7
Solomayer, E.F.8
Fehm, T.9
Holtrich, U.10
Becker, S.11
Karn, T.12
-
14
-
-
84873039798
-
Expression profifile of receptor activator of nuclear-kappaB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer
-
Owen S, Ye L, Sanders AJ, Mason MD and Jiang WG. Expression profifile of receptor activator of nuclear-kappaB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Anticancer Research. 2013; 33:199-206.
-
(2013)
Anticancer Research
, vol.33
, pp. 199-206
-
-
Owen, S.1
Ye, L.2
Sanders, A.J.3
Mason, M.D.4
Jiang, W.G.5
-
15
-
-
84881248940
-
Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6
-
Zhang H, Wu C, Matesic LE, Li X, Wang Z, Boyce BF and Xing L. Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. The Journal of biological chemistry. 2013; 288:22359-22368.
-
(2013)
The Journal of biological chemistry
, vol.288
, pp. 22359-22368
-
-
Zhang, H.1
Wu, C.2
Matesic, L.E.3
Li, X.4
Wang, Z.5
Boyce, B.F.6
Xing, L.7
-
16
-
-
0034735773
-
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma
-
Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K and Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000; 408:600-605.
-
(2000)
Nature
, vol.408
, pp. 600-605
-
-
Takayanagi, H.1
Ogasawara, K.2
Hida, S.3
Chiba, T.4
Murata, S.5
Sato, K.6
Takaoka, A.7
Yokochi, T.8
Oda, H.9
Tanaka, K.10
Nakamura, K.11
Taniguchi, T.12
-
17
-
-
70349129576
-
Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia
-
Nakajima A, Sanjay A, Chiusaroli R, Adapala NS, Neff L, Itzsteink C, Horne WC and Baron R. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. Journal of bone and mineral research: the offificial journal of the American Society for Bone and Mineral Research. 2009; 24:1162-1172.
-
(2009)
Journal of bone and mineral research: the offificial journal of the American Society for Bone and Mineral Research
, vol.24
, pp. 1162-1172
-
-
Nakajima, A.1
Sanjay, A.2
Chiusaroli, R.3
Adapala, N.S.4
Neff, L.5
Itzsteink, C.6
Horne, W.C.7
Baron, R.8
-
18
-
-
84870249011
-
cIAP1/2 negatively regulate RANKL-induced osteoclastogenesis through the inhibition of NFATc1 expression
-
Yamaguchi N, Yokota M, Taguchi Y, Gohda J and Inoue J. cIAP1/2 negatively regulate RANKL-induced osteoclastogenesis through the inhibition of NFATc1 expression. Genes to cells: devoted to molecular & cellular mechanisms. 2012; 17:971-981.
-
(2012)
Genes to cells: devoted to molecular & cellular mechanisms
, vol.17
, pp. 971-981
-
-
Yamaguchi, N.1
Yokota, M.2
Taguchi, Y.3
Gohda, J.4
Inoue, J.5
-
19
-
-
38349118587
-
The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling
-
Lee Y, Hyung SW, Jung HJ, Kim HJ, Staerk J, Constantinescu SN, Chang EJ, Lee ZH, Lee SW and Kim HH. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood. 2008; 111:885-893.
-
(2008)
Blood
, vol.111
, pp. 885-893
-
-
Lee, Y.1
Hyung, S.W.2
Jung, H.J.3
Kim, H.J.4
Staerk, J.5
Constantinescu, S.N.6
Chang, E.J.7
Lee, Z.H.8
Lee, S.W.9
Kim, H.H.10
-
20
-
-
0030997067
-
Regulating protein degradation by ubiquitination
-
Weissman AM. Regulating protein degradation by ubiquitination. Immunology today. 1997; 18:189-198.
-
(1997)
Immunology today
, vol.18
, pp. 189-198
-
-
Weissman, A.M.1
-
21
-
-
84872202144
-
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis
-
Sévère N, Dieudonné FX and Marie PJ. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death and Disease. 2013; 4:e463.
-
(2013)
Cell Death and Disease
, vol.4
-
-
Sévère, N.1
Dieudonné, F.X.2
Marie, P.J.3
-
22
-
-
84862913772
-
Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration
-
Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Liu Y and Qu X. Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration. Molecular medicine reports. 2012; 5:580-584.
-
(2012)
Molecular medicine reports
, vol.5
, pp. 580-584
-
-
Zhang, L.1
Teng, Y.2
Zhang, Y.3
Liu, J.4
Xu, L.5
Qu, J.6
Hou, K.7
Liu, Y.8
Qu, X.9
-
23
-
-
84864359162
-
Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells
-
Yan S, Qu X, Xu Ca, Zhu Z, Zhang L, Xu L, Song N, Teng Y and Liu Y. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Journal of Cancer Research and Clinical Oncology. 2012; 138:1279-1289.
-
(2012)
Journal of Cancer Research and Clinical Oncology
, vol.138
, pp. 1279-1289
-
-
Yan, S.1
Qu, X.2
Ca, X.3
Zhu, Z.4
Zhang, L.5
Xu, L.6
Song, N.7
Teng, Y.8
Liu, Y.9
-
24
-
-
67649313308
-
Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals
-
Qu X, Zhang Y, Li Y, Hu X, Xu Y, Xu L, Hou K, Sada K and Liu Y. Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals. FEBS Letters. 2009; 583:2255-2262.
-
(2009)
FEBS Letters
, vol.583
, pp. 2255-2262
-
-
Qu, X.1
Zhang, Y.2
Li, Y.3
Hu, X.4
Xu, Y.5
Xu, L.6
Hou, K.7
Sada, K.8
Liu, Y.9
-
25
-
-
1442308053
-
Negative regulation of Fc RI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b
-
Qu X. Negative regulation of Fc RI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood. 2004; 103:1779-1786.
-
(2004)
Blood
, vol.103
, pp. 1779-1786
-
-
Qu, X.1
-
26
-
-
41149145089
-
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b
-
Qiao G, Li Z, Molinero L, Alegre ML, Ying H, Sun Z, Penninger JM and Zhang J. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Molecular and cellular biology. 2008; 28:2470-2480.
-
(2008)
Molecular and cellular biology
, vol.28
, pp. 2470-2480
-
-
Qiao, G.1
Li, Z.2
Molinero, L.3
Alegre, M.L.4
Ying, H.5
Sun, Z.6
Penninger, J.M.7
Zhang, J.8
-
27
-
-
78650961494
-
Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration
-
Duan L, Raja SM, Chen G, Virmani S, Williams SH, Clubb RJ, Mukhopadhyay C, Rainey MA, Ying G, Dimri M, Chen J, Reddi AL, Naramura M, et al. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration. The Journal of biological chemistry. 2011; 286:620-633.
-
(2011)
The Journal of biological chemistry
, vol.286
, pp. 620-633
-
-
Duan, L.1
Raja, S.M.2
Chen, G.3
Virmani, S.4
Williams, S.H.5
Clubb, R.J.6
Mukhopadhyay, C.7
Rainey, M.A.8
Ying, G.9
Dimri, M.10
Chen, J.11
Reddi, A.L.12
Naramura, M.13
-
28
-
-
33645287732
-
Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45
-
Okabe S, Tauchi T, Ohyashiki K and Broxmeyer HE. Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45. Blood cells, molecules & diseases. 2006; 36:308-314.
-
(2006)
Blood cells, molecules & diseases
, vol.36
, pp. 308-314
-
-
Okabe, S.1
Tauchi, T.2
Ohyashiki, K.3
Broxmeyer, H.E.4
-
29
-
-
84855224166
-
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway
-
Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y and Qu X. C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncology letters. 2012; 3:395-400.
-
(2012)
Oncology letters
, vol.3
, pp. 395-400
-
-
Zhang, L.1
Teng, Y.2
Zhang, Y.3
Liu, J.4
Xu, L.5
Qu, J.6
Hou, K.7
Yang, X.8
Liu, Y.9
Qu, X.10
-
30
-
-
84855516339
-
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
-
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damiao R, Tammela TL, Egerdie B, Van Poppel H, et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet. 2012; 379:39-46.
-
(2012)
Lancet
, vol.379
, pp. 39-46
-
-
Smith, M.R.1
Saad, F.2
Coleman, R.3
Shore, N.4
Fizazi, K.5
Tombal, B.6
Miller, K.7
Sieber, P.8
Karsh, L.9
Damiao, R.10
Tammela, T.L.11
Egerdie, B.12
Van Poppel, H.13
-
31
-
-
84864611213
-
Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor
-
Iranikhah M, Wilborn TW, Wensel TM and Ferrell JB. Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor. Pharmacotherapy. 2012; 32:274-284.
-
(2012)
Pharmacotherapy
, vol.32
, pp. 274-284
-
-
Iranikhah, M.1
Wilborn, T.W.2
Wensel, T.M.3
Ferrell, J.B.4
-
32
-
-
79551568488
-
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study
-
Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. Journal of Clinical Oncology. 2010; 28:5132-5139.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 5132-5139
-
-
Stopeck, A.T.1
Lipton, A.2
Body, J.J.3
Steger, G.G.4
Tonkin, K.5
de Boer, R.H.6
Lichinitser, M.7
Fujiwara, Y.8
Yardley, D.A.9
Viniegra, M.10
Fan, M.11
Jiang, Q.12
Dansey, R.13
-
33
-
-
80053135821
-
RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation
-
Tang ZN, Zhang F, Tang P, Qi XW and Jiang J. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation. Oncology reports. 2011; 26:1243-1250.
-
(2011)
Oncology reports
, vol.26
, pp. 1243-1250
-
-
Tang, Z.N.1
Zhang, F.2
Tang, P.3
Qi, X.W.4
Jiang, J.5
-
34
-
-
78651256353
-
Vitamin C-defificiency stimulates osteoclastogenesis with an increase in RANK expression
-
Hie M and Tsukamoto I. Vitamin C-defificiency stimulates osteoclastogenesis with an increase in RANK expression. The Journal of nutritional biochemistry. 2011; 22:164-171.
-
(2011)
The Journal of nutritional biochemistry
, vol.22
, pp. 164-171
-
-
Hie, M.1
Tsukamoto, I.2
-
35
-
-
79955785090
-
Hypoxia induces RANK and RANKL expression by activating HIF-1alpha in breast cancer cells
-
Tang ZN, Zhang F, Tang P, Qi XW and Jiang J. Hypoxia induces RANK and RANKL expression by activating HIF-1alpha in breast cancer cells. Biochemical and biophysical research communications. 2011; 408:411-416.
-
(2011)
Biochemical and biophysical research communications
, vol.408
, pp. 411-416
-
-
Tang, Z.N.1
Zhang, F.2
Tang, P.3
Qi, X.W.4
Jiang, J.5
-
36
-
-
84355162093
-
Receptor activator for nuclear factor kappa B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis
-
Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y and Qu X. Receptor activator for nuclear factor kappa B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis. Journal of clinical pathology. 2012; 65:36-40.
-
(2012)
Journal of clinical pathology
, vol.65
, pp. 36-40
-
-
Zhang, L.1
Teng, Y.2
Zhang, Y.3
Liu, J.4
Xu, L.5
Qu, J.6
Hou, K.7
Yang, X.8
Liu, Y.9
Qu, X.10
-
37
-
-
77953115551
-
The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival
-
Broustas CG, Ross JS, Yang Q, Sheehan CE, Riggins R, Noone AM, Haddad BR, Seillier-Moiseiwitsch F, Kallakury BV, Haffty BG, Clarke R and Kasid UN. The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clinical cancer research: an offificial journal of the American Association for Cancer Research. 2010; 16:2939-2948.
-
(2010)
Clinical cancer research: an offificial journal of the American Association for Cancer Research
, vol.16
, pp. 2939-2948
-
-
Broustas, C.G.1
Ross, J.S.2
Yang, Q.3
Sheehan, C.E.4
Riggins, R.5
Noone, A.M.6
Haddad, B.R.7
Seillier-Moiseiwitsch, F.8
Kallakury, B.V.9
Haffty, B.G.10
Clarke, R.11
Kasid, U.N.12
-
38
-
-
84890527263
-
Cbl-b enhances sensitivity to 5-fluorouracil via EGFR-and mitochondria-mediated pathways in gastric cancer cells
-
Feng D, Ma Y, Liu J, Xu L, Zhang Y, Qu J, Liu Y and Qu X. Cbl-b enhances sensitivity to 5-fluorouracil via EGFR-and mitochondria-mediated pathways in gastric cancer cells. International journal of molecular sciences. 2013; 14:24399-24411.
-
(2013)
International journal of molecular sciences
, vol.14
, pp. 24399-24411
-
-
Feng, D.1
Ma, Y.2
Liu, J.3
Xu, L.4
Zhang, Y.5
Qu, J.6
Liu, Y.7
Qu, X.8
|